Additionally, the release of several cytokines in GBS (tumor necrosis factor-α, interleukin-6, interferon-γ, and IL-17) (29) responsible for systemic immune activation, which, in our hypothesis, could lead to endothelial dysfunction and altered vascular permeability, is seen in PRES (3). The gene discussed is IL6; the disease is endothelial dysfunction.